Overview
Mark Kanemori is a Radiation Oncologist practicing medicine in Honolulu, Hawaii.
His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
347 N Kuakini St, Honolulu, HI 96817
Queens Medical Center
Stuart Tsuji is a Radiation Oncologist practicing medicine in Honolulu, Hawaii. Dr. Tsuji is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Breast Cancer in Men, and Pleuropulmonary Blastoma. Dr. Tsuji is currently accepting new patients.
Queens Medical Center
Anthony Michaud is a Radiation Oncologist practicing medicine in Honolulu, Hawaii. Dr. Michaud is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Pancreatic Cancer, and Familial Pancreatic Cancer.
Kaiser Permanente Medical Center
Christina Speirs is a Radiation Oncologist practicing medicine in Honolulu, Hawaii. Dr. Speirs is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Breast Cancer, Pleuropulmonary Blastoma, and Familial Pancreatic Cancer. Dr. Speirs is currently accepting new patients.
Frequently Asked Questions about Dr. Mark T. Kanemori
How do I make an appointment with Dr. Mark T. Kanemori?
You can book an appointment with Dr. Mark T. Kanemori by calling their office at 808-547-9548. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark T. Kanemori a top-rated expert for Primitive Neuroectodermal Tumor (PNET)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark T. Kanemori is classified as an Experienced expert for Primitive Neuroectodermal Tumor (PNET), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark T. Kanemori specialize in?
While Dr. Mark T. Kanemori is a Radiation Oncology, they have specific expertise in Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Prostate Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Mark T. Kanemori accept my insurance?
Dr. Mark T. Kanemori accepts most major insurance plans, including HMSA and UnitedHealthcare. We recommend calling the office directly at 808-547-9548 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue SarcomaDr. Kanemori isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Kanemori isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Kanemori isExperienced. Learn about Anal Cancer.
- AngiosarcomaDr. Kanemori isExperienced. Learn about Angiosarcoma.
- Bone TumorDr. Kanemori isExperienced. Learn about Bone Tumor.
- Breast CancerDr. Kanemori isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Kanemori isExperienced. Learn about EGFR Positive Lung Cancer.
- Epithelioid SarcomaDr. Kanemori isExperienced. Learn about Epithelioid Sarcoma.
- Familial Pancreatic CancerDr. Kanemori isExperienced. Learn about Familial Pancreatic Cancer.
- Familial Prostate CancerDr. Kanemori isExperienced. Learn about Familial Prostate Cancer.
- FibrosarcomaDr. Kanemori isExperienced. Learn about Fibrosarcoma.
- Follicular LymphomaDr. Kanemori isExperienced. Learn about Follicular Lymphoma.
- HER-2 Positive Breast CancerDr. Kanemori isExperienced. Learn about HER-2 Positive Breast Cancer.
- Intraductal PapillomaDr. Kanemori isExperienced. Learn about Intraductal Papilloma.
- Large-Cell Lung CarcinomaDr. Kanemori isExperienced. Learn about Large-Cell Lung Carcinoma.
- LiposarcomaDr. Kanemori isExperienced. Learn about Liposarcoma.
- Lung AdenocarcinomaDr. Kanemori isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Kanemori isExperienced. Learn about Lung Cancer.
- Marginal Zone Lymphoma (MZL)Dr. Kanemori isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- MesenchymomaDr. Kanemori isExperienced. Learn about Mesenchymoma.
- Metastatic Brain TumorDr. Kanemori isExperienced. Learn about Metastatic Brain Tumor.
- Myxoid LiposarcomaDr. Kanemori isExperienced. Learn about Myxoid Liposarcoma.
- Nasopharyngeal CarcinomaDr. Kanemori isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Kanemori isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pancreatic CancerDr. Kanemori isExperienced. Learn about Pancreatic Cancer.
- Pleuropulmonary BlastomaDr. Kanemori isExperienced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Kanemori isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Kanemori isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Prostate CancerDr. Kanemori isExperienced. Learn about Prostate Cancer.
- Rhabdomyosarcoma EmbryonalDr. Kanemori isExperienced. Learn about Rhabdomyosarcoma Embryonal.
- Small Cell Lung Cancer (SCLC)Dr. Kanemori isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Kanemori isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Undifferentiated Pleomorphic SarcomaDr. Kanemori isExperienced. Learn about Undifferentiated Pleomorphic Sarcoma.